Parathyroid Allotransplantation
Parathyroid Allotransplantation - Related Videos
10:31
Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
0 Views •
Cited by 5 •
2017
Currently any kind of vascularized composite allotransplantation depends on long-term-immunosuppression, difficult to support for non-life-critical indications. We present a new porcine tibial VCA model that can be used to study bone VCA and demonstrate the use of surgical angiogenesis to maintain bone viability without the need of long-term immune-modulation.
07:13
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
0 Views •
Cited by 4 •
2017
Mice with acquired hypoparathyroidism would be useful for studying novel drug therapies for hypoparathyroidism. Two procedures to create such mice are demonstrated. The GFP-PTX mouse is generated by surgical parathyroidectomy guided by green fluorescing parathyroid glands. A second, non-surgical approach is based on parathyroid-specific expression of the diphtheria toxin receptor.
00:59
The Parathyroid Glands
0 Views •
2024
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis. Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
06:53
Heterotopic Hindlimb-to-Neck Transplantation in the Mouse: A Supermicrosurgical Model of Vascularized Composite Allotransplantation
0 Views •
2026
We present a reproducible mouse model of heterotopic hindlimb-to-neck vascularized composite allotransplantation. This supermicrosurgical protocol, involving 0.3-0.5 mm vessel anastomoses, integrates nylon filament guidance and venous cuffing. It provides a reliable platform for translational studies on tolerance, ischemia-reperfusion injury, and immunological mechanisms in vascularized composite allotransplantation.
09:30
Procurement for a Vascularized and Reinnervated Abdominal Wall Allotransplantation
0 Views •
2025
This protocol describes a step-by-step procedure for harvesting a vascularized and reinnervated abdominal wall allograft, detailing its anatomic landmarks, technical requirements, and future potential clinical applications.
FAQs
Because the donor and recipient are genetically different, the recipient may identify implanted parathyroid tissue as foreign. Immunosuppression is therefore relevant to protecting the graft from immune rejection, but its requirement also shapes the approach’s safety and practicality. Preserving hormone-producing tissue is not sufficient if immune injury prevents long-term graft survival.
Functional tissue must do more than release parathyroid hormone continuously. After implantation, donor cells need an established blood supply and must respond to changing calcium concentrations. This feedback behavior matters because the intended benefit is regulation of calcium homeostasis, rather than simply adding a fixed source of hormone that cannot adjust to the recipient’s physiological state.
Blood supply allows implanted donor cells to remain viable and function, whereas graft survival describes whether that function persists over time. Distinguishing these concerns is important when evaluating transplantation, since initial establishment of a blood supply would not necessarily demonstrate durable parathyroid hormone production or protection from later immune rejection.
Parathyroid allotransplantation is being investigated mainly for severe or permanent hypoparathyroidism, especially when conventional hormone replacement is inadequate or impractical. This places the approach within a treatment-selection decision rather than routine replacement for every patient. The relevant clinical question is whether potential restoration of graft-derived hormone production justifies the procedure and its immune and safety challenges.
Compared with conventional hormone replacement, a functioning graft could reduce dependence on lifelong medication and improve control of calcium and phosphate balance. That potential advantage does not eliminate treatment trade-offs: recipients may still face immune rejection, uncertain graft survival, and procedural safety concerns. The comparison therefore involves both metabolic control and the burdens of transplantation.
The major challenges are maintaining a blood supply, preserving graft survival, preventing immune rejection, and ensuring appropriate hormone release after implantation. Procedural safety also remains important when researchers evaluate the method. Progress depends on showing that transplanted tissue can provide sustained regulation of calcium and phosphate balance without creating unacceptable risks for recipients.